CD24 and breast cancer: In a parallel experimental set using the razor-wound migration assay method, human breast cancer cell line MCF-7 furnished higher expression of CSC-markers (that is, CD44+/CD24-/low) in the migrating population as compared with the non-migrating fraction of cells as evident from our confocal data (Figure 1C).